Filed before 2025Filed 17 December 2021
Attivare Therapeutics, Inc. has sold $5.88M so far
Attivare Therapeutics, Inc., a company based in Natick, MA, has sold $5.88M so far in its equity round, according to a filing dated 17 December 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 17 December 2021
- First filed
- 1 September 2021
- Round
- Equity round (amended filing)
- Amount sold
- $5.88M
- Offering size
- $7.83M
- Investors so far
- 23
- Based in
- Natick, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 35% of the 2,220 tracked raises with an amount filed in 2021.
Attivare Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 Dec 2021 | Amended filing | $5.88M | This raise |
| 1 Sep 2021 | New filing | $4.83M | This raise |
More with FRx on the board
- Neurofold Therapeutics Inc.$6.5M
- Contraline, Inc.$55.8M
- Junction Health, Inc.$3.54M
- Ancilia Biosciences, Inc.$10.1M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.